Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $63,164.09 -0.94%
Ethereum $1,877.24 -0.83%
BNB $608.38 -0.72%
Optimism $0.09 +0.03%
Arbitrum $0.08 -1.14%
Solana $75.60 -1.03%
Polygon $0.22 +2.77%
Cosmos $1.56 +11.51%
Avalanche $6.41 -1.79%

Bitcoin $63,164.09 -0.94%
Ethereum $1,877.24 -0.83%
BNB $608.38 -0.72%
Optimism $0.09 +0.03%
Arbitrum $0.08 -1.14%
Solana $75.60 -1.03%
Polygon $0.22 +2.77%
Cosmos $1.56 +11.51%
Avalanche $6.41 -1.79%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B